Reuters logo
BRIEF-Roche says Ocrevus reduced measures of MS progression
2017年6月23日 / 早上6点44分 / 5 个月前

BRIEF-Roche says Ocrevus reduced measures of MS progression

June 23 (Reuters) - Roche Holding Ag

* Says new data at ean show roche’s ocrevus (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary progressive multiple sclerosis Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below